CASON BOCK: Open Payments
NPI 1871525402 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 48 payments from 18 companies in 2025. Trend: 2023 $903 · 2024 $1,339 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 18 | $203 |
| UROGEN PHARMA, INC. | 5 | $121 |
| Boston Scientific Corporation | 4 | $72 |
| PFIZER INC. | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Calyxo, Inc. | 1 | $36 |
| COLOPLAST CORP | 2 | $30 |
| Antares Pharma, Inc. | 2 | $29 |
| Janssen Biotech, Inc. | 2 | $27 |
| TOLMAR, INC. | 1 | $25 |
Products named: ORGOVYX, JELMYTO, SpaceOAR VUE System - 10mL, XTANDI, ZUSDURI, GEMTESA, Nubeqa, CVAC ASPIRATION SYSTEM.
Industry payments across NE — which companies pay providers there.
